|
VTGN Vistagen Therapeutics Inc 1411685 |
| Balance Sheet |
|
Current Assets
|
$46,943,000.00 |
|
Assets
|
$48,564,000.00 |
|
Current Liabilities
|
$12,795,000.00 |
|
Liabilities
|
$13,044,000.00 |
|
Equity
|
$35,520,000.00 |
|
Shares Out
|
41032453.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-66,436,000.00 |
|
Investing Cash Flow
|
$-877,000.00 |
| Market Analysis |
Market Cap
|
$9,847,788.72 |
|
Price
|
$0.25 |
|
BVPS
|
0.87 |
|
PB
|
0.28 |
|
EPS
|
-1.83 |
|
PS
|
8.08 |
|
FCF
|
$-66,436,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:41 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-12 |
-0.45 |
|
| Jul |
Aug |
Sep |
| 2026-06-15 |
-1.83 |
|
|
2025-08-07 |
-0.47 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.54 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VTGN documents filed with the SEC.
VTGN Filings
Clear
